World Vaccines Market 2013-2023 provides independent research and analysis. There you get competitive intelligence found only in our work, finding where the money lies. Explore progress and possibilities.
The rise of H7N9 influenza in 2013 shows how pandemic flu creates needs. Also, the therapeutic vaccines segment has a strong R&D pipeline. It holds over 20 late-stage candidates for solid-tumour cancers and other chronic diseases. Find promising research.
Besides revenue forecasting to 2023, our new study gives you historical data, recent results, growth rates, and market shares. There you will find original analysis, with business outlooks and developments (R&D). You also get two interviews, 50 charts, and 91 tables.
Find individual forecasts for four submarkets at the world level:
Our analyses show you individual revenue forecasts to 2023 for 11 national markets:
In particular, our report discusses these medical technologies:
Developments for those immunological treatments hold strength, variety, and promise. See what's possible there for large pharmaceutical companies and biopharma specialists.
Visiongain is a trading partner with the US Federal Government.